首页 | 本学科首页   官方微博 | 高级检索  
检索        

非小细胞肺癌中P—糖蛋白的表达与预后的研究
引用本文:孙丽梅,邱雪杉.非小细胞肺癌中P—糖蛋白的表达与预后的研究[J].中国医科大学学报,1999,28(6):424-425.
作者姓名:孙丽梅  邱雪杉
作者单位:中国医科大学基础医学院病理学教研室!沈阳110001
基金项目:卫生部科研基金!资助项目,98-1-178
摘    要:目的:明确化疗前非小细胞肺癌(NSCLC)中是否存在原发耐药;是否影响NSCLC患者的预后。方法:采用S-P免疫组化方法,检测97例化疗前NSCLC患者中P-糖蛋白(Pgp)的表达情况。结果:Pgp在腺癌中高表达,与NSCLC的淋巴结转移相关;且Pgp表达对NSCLC患者预后有影响。结论:NSCLC中存在原发耐药,且Pgp表达是NSCLC患者预后的影响因素之一。

关 键 词:非小细胞肺癌  耐药基因  预后  S-P免疫组化方法

Prognostic Significance of the Expression of P Glycoprotein in Primary Nonsmall Cell Lung Cancer
Sun Limei,Qiu Xueshan,Wang Enhua,et al.Prognostic Significance of the Expression of P Glycoprotein in Primary Nonsmall Cell Lung Cancer[J].Journal of China Medical University,1999,28(6):424-425.
Authors:Sun Limei  Qiu Xueshan  Wang Enhua  
Abstract:Objective: Our paper was designed to explicate whether primary drug resistance exist in untreated patients of nonsmall cell lung carcer (NSCLC) and to analysis whether expressions of Pgp affect theirs prognosis. Methods: S P immunohistochemical method was used to examine expressions of Pgp in 97 samples of primary NSCLC. Results: High expression of Pgp was correlated to lymphnode metastasis and adenocarcinoma. Conclusion: Conclusion: Primary drug resistance might existed in NSCLC and the expression of Pgp might play as a significant prognostic factor for the patients with NSCLC.
Keywords:nonsmall  cell lung cancer  multidrug  resistance gene  prognosis  S  P immunohistochemical method
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号